FADINI, GIAN PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 41.946
AS - Asia 21.857
EU - Europa 10.644
AF - Africa 3.814
SA - Sud America 3.509
Continente sconosciuto - Info sul continente non disponibili 707
OC - Oceania 372
Totale 82.849
Nazione #
US - Stati Uniti d'America 39.579
SG - Singapore 6.607
CN - Cina 3.816
VN - Vietnam 3.031
IT - Italia 2.856
HK - Hong Kong 2.157
BR - Brasile 2.029
BD - Bangladesh 1.302
FI - Finlandia 855
FR - Francia 796
DE - Germania 788
IN - India 718
GB - Regno Unito 522
SE - Svezia 521
PL - Polonia 455
CA - Canada 418
RU - Federazione Russa 396
NL - Olanda 365
IQ - Iraq 359
AR - Argentina 335
UA - Ucraina 325
TR - Turchia 301
JP - Giappone 275
MX - Messico 248
ZA - Sudafrica 222
PH - Filippine 212
PK - Pakistan 205
ID - Indonesia 194
CO - Colombia 191
SA - Arabia Saudita 191
EC - Ecuador 184
ES - Italia 180
IE - Irlanda 179
BJ - Benin 163
VE - Venezuela 162
JM - Giamaica 154
CR - Costa Rica 150
UZ - Uzbekistan 149
CI - Costa d'Avorio 148
AE - Emirati Arabi Uniti 141
MA - Marocco 140
MY - Malesia 137
EG - Egitto 131
PE - Perù 128
NI - Nicaragua 126
AT - Austria 125
TN - Tunisia 125
KR - Corea 121
PY - Paraguay 120
AL - Albania 118
AO - Angola 117
GR - Grecia 116
DZ - Algeria 115
JO - Giordania 115
CL - Cile 112
IL - Israele 112
KE - Kenya 112
BE - Belgio 110
HN - Honduras 109
PA - Panama 108
GA - Gabon 107
TW - Taiwan 106
ET - Etiopia 103
LB - Libano 102
TH - Thailandia 101
PS - Palestinian Territory 99
AZ - Azerbaigian 98
CH - Svizzera 98
MD - Moldavia 98
TT - Trinidad e Tobago 98
SN - Senegal 97
SK - Slovacchia (Repubblica Slovacca) 96
BG - Bulgaria 95
KZ - Kazakistan 95
CZ - Repubblica Ceca 94
GT - Guatemala 94
KG - Kirghizistan 94
MK - Macedonia 94
RS - Serbia 94
IR - Iran 93
BO - Bolivia 92
LV - Lettonia 92
CV - Capo Verde 91
NP - Nepal 91
RO - Romania 91
ML - Mali 90
AM - Armenia 89
BY - Bielorussia 89
PT - Portogallo 89
TZ - Tanzania 89
UG - Uganda 89
GH - Ghana 88
LA - Repubblica Popolare Democratica del Laos 88
PR - Porto Rico 88
DK - Danimarca 87
DO - Repubblica Dominicana 87
EE - Estonia 87
HU - Ungheria 87
BA - Bosnia-Erzegovina 85
BZ - Belize 85
Totale 78.006
Città #
Ashburn 4.868
Fairfield 4.269
Singapore 4.049
San Jose 3.674
Woodbridge 2.556
Houston 2.302
Hong Kong 1.933
Ann Arbor 1.768
Chandler 1.692
Seattle 1.592
Cambridge 1.493
Wilmington 1.346
Ho Chi Minh City 885
Council Bluffs 824
Beijing 756
Hanoi 702
Jacksonville 689
Santa Clara 683
Los Angeles 645
Boardman 592
New York 507
Princeton 464
Helsinki 449
San Diego 429
Lauterbourg 366
Roxbury 311
Chicago 289
Medford 273
Padova 252
Guangzhou 250
Milan 243
Bytom 242
Des Moines 237
The Dalles 222
Munich 202
São Paulo 198
Rome 197
Nanjing 183
Da Nang 179
Tokyo 175
Buffalo 168
Dallas 164
Cotonou 156
Shanghai 151
Dublin 147
Dong Ket 146
Abidjan 140
Baghdad 139
Orem 139
Tashkent 135
Warsaw 124
Phoenix 123
London 122
Managua 115
Atlanta 114
Denver 113
Frankfurt am Main 108
San José 105
Libreville 104
Amman 103
Haiphong 103
Panama City 101
Turku 101
Chennai 94
Luanda 92
Salt Lake City 92
Dakar 91
Nairobi 91
Brooklyn 90
Baku 89
Hefei 89
Montreal 89
Kingston 88
Naples 88
Kampala 87
Vienna 87
Johannesburg 86
Amsterdam 85
Bamako 81
Lima 81
Yerevan 81
Bishkek 80
Addis Ababa 79
Padua 79
Nassau 77
Toronto 77
Castries 76
Praia 76
San Francisco 76
Shenyang 76
Vientiane 76
Lahore 75
Nouakchott 75
Harare 74
Istanbul 74
Riga 74
Boston 73
Dearborn 73
Phnom Penh 73
Conakry 71
Totale 48.922
Nome #
Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence 655
Hyperglycemic Crises in Adults With Diabetes: A Consensus Report 611
Convenience versus Biological Significance: Are PMA-Differentiated THP-1 Cells a Reliable Substitute for Blood-Derived Macrophages When Studying in Vitro Polarization? 421
DPP-4 inhibitors moderate the risk of genitourinary tract infections associated with SGLT2 inhibitors 407
Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patients. 399
NETosis delays diabetic wound healing in mice and humans 390
Hyperglycaemic crises in adults with diabetes: a consensus report 386
Bone marrow macrophages contribute to diabetic stem cell mobilopathy by producing Oncostatin M. 369
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration 367
Clinical Efficacy and Safety of Angiogenesis Inhibitors: Sex Differences and Current Challenges 364
Alternative Activation of Human Macrophages Is Rescued by Estrogen Treatment in Vitro and Impaired by Menopausal Status. 349
Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19 344
Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients 341
NETosis is induced by high glucose and associated with type 2 diabetes. 340
Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history 331
Acute effects of linagliptin on progenitor cells, monocyte phenotypes, and soluble mediators in type 2 diabetes 330
Phenotypic activation and pharmacological outcomes of spontaneously differentiated human monocyte-derived macrophages. 330
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study 328
Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study 326
Circulating Endothelial Progenitor Cells Are Reduced In Peripheral Vascular Complications of Type 2 Diabetes Mellitus 324
Diabetes-associated myelopoiesis drives stem cell mobilopathy through an OSM-p66Shc signaling pathway 324
Diabetes Limits Stem Cell Mobilization Following G-CSF but not Plerixafor. 319
Loss of mitochondrial calcium uniporter rewires skeletal muscle metabolism and substrate preference 317
miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways 316
Non-genomic mechanisms in the estrogen regulation of glycolytic protein levels in endothelial cells 316
Lung Ultrasound Patterns and Clinical-Laboratory Correlates during COVID-19 Pneumonia: A Retrospective Study from North East Italy 315
Low p66shc with high serpinb3 levels favors necroptosis and better survival in hepatocellular carcinoma 313
Carotid Plaque Calcification Predicts Future Cardiovascular Events in Type 2 Diabetes 312
Mitochondrial Calcium Uptake Is Instrumental to Alternative Macrophage Polarization and Phagocytic Activity 307
Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts 302
A perspective on NETosis in diabetes and cardiometabolic disorders 302
Sarcoidosis is a Th1/Th17 multisystem disorder 299
Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes 299
Performance of the Steno type 1 risk engine for cardiovascular disease prediction in Italian patients with type 1 diabetes 299
Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine. 298
Deintensification of basal-bolus insulin after initiation of GLP-1RA in patients with type 2 diabetes under routine care 297
p66Shc deletion or deficiency protects from obesity but not metabolic dysfunction in mice and humans 296
The continuum of monocyte phenotypes: Experimental evidence and prognostic utility in assessing cardiovascular risk 296
An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy. 296
Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double-blind, placebo-controlled trial 294
Arrhythmogenic Cardiomyopathy Is a Multicellular Disease Affecting Cardiac and Bone Marrow Mesenchymal Stromal Cells 291
17beta-estradiol modulates monocyte heterogeneity and macrophage polarization 289
Clones of Interstitial Cells From Bovine Aortic Valve Exhibit Different Calcifying Potential When Exposed to Endotoxin and Phosphate 287
Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs. 287
Cross-talk of healthy and impaired human tissues for dissection of disease pathogenesis 282
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study 282
Metformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes. A randomized controlled trial. 279
Development of a multiphoton-multicolor and super-resolution STED microscope for in vivo experiments 279
The impact of clinical history on the predictive performance of machine learning and deep learning models for renal complications of diabetes 276
The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo 276
Inhibition of SGLT-2 rescues bone marrow cell traffic for vascular repair. Role of glucose control and ketogenesis 275
A view on the quality of diabetes care in Italy and the role of Diabetes Clinics from the 2018 ARNO Diabetes Observatory 273
High Abundance Proteins Depletion vs Low Abundance Proteins Enrichment: Comparison of Methods to Reduce the Plasma Proteome Complexity 271
The peritoneum as a natural scaffold for vascular regeneration. 271
Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial 271
Circulating myeloid calcifying cells have anti-angiogenic activity via thrombospondin-1 overexpression 271
Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study 270
Atorvastatin Reduces Circulating Osteoprogenitor Cells and T-Cell RANKL Expression in Osteoporotic Women: Implications for the Bone-Vascular Axis 269
Head-to-head comparison between flash and continuous glucose monitoring systems in outpatients with type 1 diabetes 268
Continuous glucose monitoring in patients with inherited metabolic disorders at risk for Hypoglycemia and Nutritional implications 268
Insulin-induced glucose control improves HDL cholesterol levels but not reverse cholesterol transport in type 2 diabetic patients. 266
A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than-additive. 266
High temporal resolution detection of patient-specific glucose uptake from human ex vivo adipose tissue on-chip. 264
Downregulation of the Longevity-Associated Protein SIRT1 in Insulin Resistance and Metabolic Syndrome. Potential Biochemical Mechanisms 264
Bisdemethoxycurcumin and Its Cyclized Pyrazole Analogue Differentially Disrupt Lipopolysaccharide Signalling in Human Monocyte-Derived Macrophages 262
Hematopoietic and Nonhematopoietic p66Shc Differentially Regulates Stem Cell Traffic and Vascular Response to Ischemia in Diabetes 261
Explainable Deep-Learning Model Reveals Past Cardiovascular Disease in Patients with Diabetes Using Free-Form Visit Reports 260
Effects of Hypoglycemia on Circulating Stem and Progenitor Cells in Diabetic Patients 259
Microangiopathy is independently associated with presence, severity and composition of carotid atherosclerosis in type 2 diabetes. 257
Use and effectiveness of dapagliflozin in routine clinical practice. An Italian multicenter retrospective study 257
Diabetes Impairs Stem Cell and Proangiogenic Cell Mobilization in Humans. 256
Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice 256
Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study 256
Effects of glucose variability on hematopoietic stem/progenitor cells in patients with type 1 diabetes 254
Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study 253
Interplay between gut microbiota and p66Shc affects obesity-associated insulin resistance 252
Pro-inflammatory monocyte-macrophage polarization imbalance in human hypercholesterolemia and atherosclerosis. 251
Endothelial properties of third-trimester amniotic fluid stem cells cultured in hypoxia 251
The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker. 250
Heme oxygenase-1 is an important modulator in limiting glucose-induced apoptosis in human umbilical vein endothelial cells 247
Cardiovascular actions of GLP-1 and incretin-based pharmacotherapy. 246
Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. 246
Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study 246
Concise Review: Perspectives and Clinical Implications of Bone Marrow and Circulating Stem Cell Defects in Diabetes 245
Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center. 243
Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19 243
Circulating Progenitor Cell Count Predicts Microvascular Outcomes in Type 2 Diabetic Patients 242
Padi4-dependent NETosis enables diet-induced gut hyperpermeability, translating dysbiosis into systemic inflammation and dysmetabolism 241
Impaired endothelial progenitor cell recruitment may contribute to heart transplant microvasculopathy. 239
Circulating Stem Cells Associate With Adiposity and Future Metabolic Deterioration in Healthy Subjects 237
Improved long-term cardiovascular outcomes after intensive versus standard screening of diabetic complications: an observational study 237
Characteristics, prevalence, and outcomes of diabetic foot ulcers in Africa. A systemic review and meta-analysis 235
Effects of dose escalating liraglutide from 1.2 to 1.8 mg in clinical practice: A case-control study 233
Peripheral blood CD34(+)KDR(+) endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population 232
Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs 232
Monocyte-macrophage polarization balance in pre-diabetic individuals. 232
Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study 232
Increased tissue endothelial progenitor cells in end-stage lung diseases with pulmonary hypertension. 231
Fixed versus flexible combination of GLP-1 receptor agonists with basal insulin in type 2 diabetes: A retrospective multicentre comparative effectiveness study 231
Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet Cultures 231
Totale 29.260
Categoria #
all - tutte 234.196
article - articoli 221.707
book - libri 1.209
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 493
Totale 457.605


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.535 0 0 698 329 282 324 252 590 318 123 511 1.108
2022/20233.485 745 373 75 452 489 433 38 250 415 42 142 31
2023/20242.057 79 293 234 146 111 218 159 77 86 242 201 211
2024/20258.643 23 579 380 319 992 265 539 663 808 405 1.469 2.201
2025/202641.948 1.672 2.999 5.389 6.957 3.927 1.814 5.282 3.421 4.477 2.424 1.948 1.638
2026/20274.265 1.735 2.239 291 0 0 0 0 0 0 0 0 0
Totale 82.849